{
    "clinical_study": {
        "@rank": "68681", 
        "acronym": "CRHACS", 
        "arm_group": [
            {
                "arm_group_label": "TREATMENT", 
                "arm_group_type": "Experimental", 
                "description": "Helmet CPAP"
            }, 
            {
                "arm_group_label": "CONTROL", 
                "arm_group_type": "Active Comparator", 
                "description": "Venturi Mask"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of study is to evaluate whether the application of a continuous positive airway\n      pressure (CPAP) after extubation in patients undergoing cardiac surgery can reduce hypoxemia\n      and re-intubation rate."
        }, 
        "brief_title": "CPAP Reduces Hypoxemia After Cardiac Surgery", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Respiratory Failure Requiring Reintubation", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Adult", 
                "Respiratory Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "We want to test the hypothesis that the application of a continuous positive airway pressure\n      (CPAP) after extubation in patients undergoing cardiac surgery can reduce hypoxemia and\n      re-intubation rate.\n\n      Primary end point:  to reduce the rate of re-intubation.\n\n      Secondary  end point:  to reduce the incidence of atelectasis, pneumonia, sepsis, the\n      mortality rate, the intensive care unit (ICU) and hospital length of stay."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing cardiac surgery on cardiopulmonary bypass\n\n          -  PaO2 /FiO2 < 200 after extubation\n\n          -  extubation time < 24 h.\n\n        Exclusion Criteria:\n\n          -  patients < 18 years old\n\n          -  extracorporeal membrane oxygenation\n\n          -  severe cardiac dysfunction (FE<25%)\n\n          -  mechanical ventilation before the intervention\n\n          -  severe COPD (patients on oxygen therapy, with a FEV1< 50%)\n\n          -  heart or lung transplantation\n\n          -  lack of consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "960", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01726140", 
            "org_study_id": "CRHACS CEI-457"
        }, 
        "intervention": [
            {
                "arm_group_label": "TREATMENT", 
                "description": "the patient will receive CPAP treatment, at a PEEP level of 10 cmH2O and a FiO2 adjusted to maintain SpO2>95%, for six hours. After three hours of treatment a blood gas analysis will be evaluated and the patient will proceed with the treatment for three more hours. At the end of the six hours, the patient will repeat a spontaneous breathing trial with a Venturi mask at FiO2 = 50%, for 15 minutes and than a blood gas analysis will be repeated: if the PaO2/FiO2 will be < 200 the patient will received a second treatment with CPAP; if PaO2/FiO2 will be >200, the patient will stop the treatment.", 
                "intervention_name": "Helmet CPAP", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "CONTROL", 
                "description": "the patient will maintain spontaneous breathing, with a system for oxygen delivery at a FiO2 adjusted to maintain SpO2>95%, for six hours. After three hours of treatment a blood gas analysis will be evaluated and the patient will proceed with the treatment for three more hours.  At the end of the six hours, the patient will do a trial for 15 minutes and after that a blood gas analysis will be repeated: if the PaO2/FiO2 will be < 200 the patient will go on with the control treatment; if PaO2 /FiO2  will be >200, the patient will stop the treatment.", 
                "intervention_name": "Venturi Mask", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "intubation", 
            "respiratory failure", 
            "cardiac surgery"
        ], 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "contact": {
                "email": "daniela.pasero@unito.it", 
                "last_name": "Daniela Pasero, MD", 
                "phone": "+390116336129"
            }, 
            "facility": {
                "address": {
                    "city": "Turin", 
                    "country": "Italy", 
                    "zip": "10126"
                }, 
                "name": "University of Turin - Department of Anesthesia and Intensive Care Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A Randomized Controlled Trial", 
        "overall_contact": {
            "email": "daniela.pasero@unito.it", 
            "last_name": "Daniela Pasero, MD", 
            "phone": "+390116336129"
        }, 
        "overall_contact_backup": {
            "email": "claudia.filippini@unito.it", 
            "last_name": "Claudia Filippini, PhD", 
            "phone": "+390116336140"
        }, 
        "overall_official": {
            "affiliation": "University of Turin", 
            "last_name": "Vito Marco VM Ranieri, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "rate of re-intubation", 
            "safety_issue": "No", 
            "time_frame": "at 28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01726140"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Turin, Italy", 
            "investigator_full_name": "Daniela Pasero", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "incidence of atelectasis", 
                "safety_issue": "No", 
                "time_frame": "at 28 days"
            }, 
            {
                "measure": "incidence of pneumonia", 
                "safety_issue": "No", 
                "time_frame": "at 28 days"
            }, 
            {
                "measure": "incidence of sepsis", 
                "safety_issue": "No", 
                "time_frame": "at 28 days"
            }, 
            {
                "measure": "mortality rate", 
                "safety_issue": "No", 
                "time_frame": "at 28 days"
            }, 
            {
                "measure": "the intensive care unit length of stay", 
                "safety_issue": "No", 
                "time_frame": "at 28 days"
            }, 
            {
                "measure": "hospital length of stay", 
                "safety_issue": "No", 
                "time_frame": "at 28 days"
            }
        ], 
        "source": "University of Turin, Italy", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Turin, Italy", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}